StocktonCA
1 week ago
HC Wainwright Reaffirms “Buy” Rating for Palatin Technologies (NYSEAMERICAN:PTN)
Posted by MarketBeat News on Jan 30th, 2025
Share on Twitter Share on Facebook Share on LinkedIn
Share on Stocktwits
?Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $17.00 price objective on the biopharmaceutical company’s stock.
Palatin Technologies Trading Up 0.7 %
NYSEAMERICAN PTN opened at $0.91 on Tuesday. Palatin Technologies has a 1-year low of $0.68 and a 1-year high of $5.22. The stock has a market capitalization of $17.77 million, a PE ratio of -0.46 and a beta of 0.90.
Get Palatin Technologies alerts:
Institutional Trading of Palatin Technologies
Several large investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of Palatin Technologies in the third quarter valued at $51,000. HB Wealth Management LLC lifted its holdings in Palatin Technologies by 86.3% in the 4th quarter. HB Wealth Management LLC now owns 110,500 shares of the biopharmaceutical company’s stock worth $127,000 after buying an additional 51,200 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in Palatin Technologies in the 2nd quarter worth $29,000. 11.50% of the stock is currently owned by institutional investors and hedge funds.